335 related articles for article (PubMed ID: 32099582)
1. Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review.
Bauersachs R; Zeymer U; Brière JB; Marre C; Bowrin K; Huelsebeck M
Cardiovasc Ther; 2019; 2019():8295054. PubMed ID: 32099582
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis.
Emery C; Torreton E; Briere JB; Evers T; Fagnani F
J Med Econ; 2020 May; 23(5):513-520. PubMed ID: 31928390
[No Abstract] [Full Text] [Related]
3. Incidence and Cost of Major Adverse Cardiovascular Events and Major Adverse Limb Events in Patients With Chronic Coronary Artery Disease or Peripheral Artery Disease.
Berger A; Simpson A; Bhagnani T; Leeper NJ; Murphy B; Nordstrom B; Ting W; Zhao Q; Berger JS
Am J Cardiol; 2019 Jun; 123(12):1893-1899. PubMed ID: 31014542
[TBL] [Abstract][Full Text] [Related]
4. Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease.
Smolderen KG; Wang K; de Pouvourville G; Brüggenjürgen B; Röther J; Zeymer U; Parhofer KG; Steg PG; Bhatt DL; Magnuson EA;
Eur J Vasc Endovasc Surg; 2012 Feb; 43(2):198-207. PubMed ID: 22001145
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and outcomes of COMPASS eligible patients in France. An analysis from the REACH Registry.
Darmon A; Elbez Y; Bhatt DL; Abtan J; Mas JL; Cacoub P; Montalescot G; Billaut-Laden I; Ducrocq G; Steg PG
Ann Cardiol Angeiol (Paris); 2020 Oct; 69(4):158-166. PubMed ID: 32778388
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of ankle-brachial index screening in patients with coronary artery disease to optimize medical management.
Minami HR; Itoga NK; George EL; Garcia-Toca M
J Vasc Surg; 2021 Dec; 74(6):2030-2039.e2. PubMed ID: 34175383
[TBL] [Abstract][Full Text] [Related]
7. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.
Grenon SM; Vittinghoff E; Owens CD; Conte MS; Whooley M; Cohen BE
Vasc Med; 2013 Aug; 18(4):176-84. PubMed ID: 23835937
[TBL] [Abstract][Full Text] [Related]
8. Comparative Assessment of Medical Resource Use and Costs Associated with Patients with Symptomatic Peripheral Artery Disease in the United States.
Chase MR; Friedman HS; Navaratnam P; Heithoff K; Simpson RJ
J Manag Care Spec Pharm; 2016 Jun; 22(6):667-75. PubMed ID: 27231794
[TBL] [Abstract][Full Text] [Related]
9. Effect of Cerebrovascular and/or Peripheral Artery Disease With or Without Attainment of Lipid Goals on Long-Term Outcomes in Patients With Coronary Artery Disease.
Volis I; Saliba W; Jaffe R; Eitan A; Zafrir B
Am J Cardiol; 2020 Aug; 128():28-34. PubMed ID: 32650921
[TBL] [Abstract][Full Text] [Related]
10. The Burden of Major Adverse Cardiac Events and Antiplatelet Prevention in Patients with Coronary or Peripheral Arterial Disease.
Khoury H; Lavoie L; Welner S; Folkerts K
Cardiovasc Ther; 2016 Apr; 34(2):115-24. PubMed ID: 26670723
[TBL] [Abstract][Full Text] [Related]
11. The burden of critical limb ischemia: a review of recent literature.
Duff S; Mafilios MS; Bhounsule P; Hasegawa JT
Vasc Health Risk Manag; 2019; 15():187-208. PubMed ID: 31308682
[TBL] [Abstract][Full Text] [Related]
12. Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature Review.
Lavoie L; Khoury H; Welner S; Briere JB
Cardiovasc Ther; 2016 Jun; 34(3):152-60. PubMed ID: 26915344
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases.
Takahara M; Iida O; Kohsaka S; Soga Y; Fujihara M; Shinke T; Amano T; Ikari Y;
Cardiovasc Diabetol; 2019 Nov; 18(1):155. PubMed ID: 31730004
[TBL] [Abstract][Full Text] [Related]
14. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
Soini E; Virtanen O; Väätäinen S; Briere JB; Bowrin K; Millier A
Adv Ther; 2020 Jul; 37(7):3348-3369. PubMed ID: 32519113
[TBL] [Abstract][Full Text] [Related]
16. Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006-2015.
Sundaram V; Bloom C; Zakeri R; Halcox J; Cohen A; Bowrin K; Briere JB; Banerjee A; Simon DI; Cleland JGF; Rajagopalan S; Quint JK
Eur Heart J; 2020 May; 41(17):1636-1649. PubMed ID: 31883328
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic burden in patients with diagnosis of peripheral arterial disease in a claims database in Japan.
Hosaka A; Miyata T; Onishi Y; Liao L; Zhang Q
Clin Ther; 2014 Aug; 36(8):1223-30, 1230.e1-4. PubMed ID: 25012730
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention.
Pereg D; Elis A; Neuman Y; Mosseri M; Segev D; Granek-Catarivas M; Lishner M; Hermoni D
Coron Artery Dis; 2014 Jan; 25(1):79-82. PubMed ID: 24128887
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of peripheral artery disease in Europe: VAS Educational Paper.
Olinic DM; Spinu M; Olinic M; Homorodean C; Tataru DA; Liew A; Schernthaner GH; Stanek A; Fowkes G; Catalano M
Int Angiol; 2018 Aug; 37(4):327-334. PubMed ID: 29936722
[TBL] [Abstract][Full Text] [Related]
20. Lessons from the REACH Registry in Europe.
Valentijn TM; Stolker RJ
Curr Vasc Pharmacol; 2012 Nov; 10(6):725-7. PubMed ID: 23259566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
